(Q37864161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Stephan Walrand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Mark W Konijnenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Roelf Valkema

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Eric P Krenning

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Renaud Lhommel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Stanislas Pauwels

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Francois Jamar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

11 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

38 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

S57-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-011-1771-7

28 January 2020

exact match

0 references

cites work

Clinical applications of newer radionuclide therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

An 86Y-labeled mirror-image oligonucleotide: influence of Y-DOTA isomers on the biodistribution in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Radiolabeling of monoclonal antibody against carcinoembryonic antigen with 88Y and biodistribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

4-Step renal dosimetry dependent on cortex geometry applied to 90Y peptide receptor radiotherapy: evaluation using a fillable kidney phantom imaged by 90Y PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

A restoration algorithm for P-32 and Y-90 bremsstrahlung emission nuclear imaging: a wavelet-neural network approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Evaluation of quantitative (90)Y SPECT based on experimental phantom studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Radiotherapy quality assurance by individualized in vivo dosimetry: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Use of single photon emission computed tomography (SPECT) to study the distribution of 90Y in patients with Baker's cysts and persistent synovitis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Scanning bremsstrahlung of yttrium-90 microspheres injected intra-arterially.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-Labeled hLL2 (Epratuzumab) in Nude Mice with CD22-Positive Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1771-7

Experimental radiotherapy of a rat rhabdomyosarcoma with 15 meV neutrons and 300 kV x-rays. II. Effects of ractionated treatments, applied five times a week for several weeks

21 January 2018

1 reference

12 December 2020

Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system

1 reference

12 December 2020

Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography

1 reference

12 December 2020

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

1 reference

12 December 2020

Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.

1 reference

12 December 2020

Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

1 reference

12 December 2020

Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

1 reference

12 December 2020

Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts.

1 reference

12 December 2020

Yttrium-90 biodistribution by yttrium-87 imaging: a theoretical feasibility analysis

1 reference

12 December 2020

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent

1 reference

12 December 2020

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

1 reference

12 December 2020

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

12 December 2020

Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics

1 reference

12 December 2020

(90)Y bremsstrahlung emission computed tomography using gamma cameras

1 reference

12 December 2020

Three-dimensional positron emission tomography imaging with 124I and 86Y

1 reference

12 December 2020

Bremsstrahlung imaging using the gamma camera: factors affecting attenuation

1 reference

12 December 2020

PET/CT for the assessment and quantification of (90)Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases

1 reference

12 December 2020

PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.

1 reference

12 December 2020

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

1 reference

12 December 2020

Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma

1 reference

12 December 2020

90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.

1 reference

12 December 2020

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

12 December 2020

Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)

1 reference

12 December 2020

Advances in radiotherapy and implications for the next century: a historical perspective

1 reference

12 December 2020

Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy

1 reference

12 December 2020

Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody

1 reference

12 December 2020

Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts

1 reference

12 December 2020

Stable bifunctional chelates of metals used in radiotherapy

1 reference

12 December 2020

Distribution in rats after intravenous injection of 88Y compounds (author's transl)

1 reference

12 December 2020

SPECT using Bremsstrahlung to quantify 90Y uptake in Baker's cysts: its application in radiation synovectomy of the knee

1 reference

12 December 2020

[Scintigraphic use of 87Y during 90Y therapy of bone metastases]

1 reference

12 December 2020

Cell kinetic model of tumour growth and regression for a rhabdomyosarcoma in the rat: undisturbed growth and radiation response to large single doses

1 reference

12 December 2020

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

1 reference

12 December 2020

Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity

1 reference

12 December 2020

A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr

1 reference

12 December 2020

Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung

1 reference

12 December 2020

Quantitative Imaging of Yttrium-86 with PET. The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions

1 reference

12 December 2020

Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters

1 reference

12 December 2020

Evaluation of quantitative planar90Y bremsstrahlung whole-body imaging

1 reference

12 December 2020

Quantitative bremsstrahlung SPECT imaging: attenuation-corrected activity determination.

1 reference

12 December 2020

10.1007/S00259-011-1771-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484382%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference